
Company Number
09547901
Next Accounts
Sep 2025
Shareholders
auric eusina ltd
transene company inc
View AllGroup Structure
View All
Industry
Manufacture of other chemical products n.e.c.
+2Registered Address
1 doughty street, london, WC1N 2PH
Website
https://biokemix.comPomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £220.1k based on a Turnover of £351.3k and 0.63x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £365.3k based on an EBITDA of £100.8k and a 3.62x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIOKEMIX WORLDWIDE LTD at £132.4k based on Net Assets of £71.9k and 1.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biokemix Worldwide Ltd is a live company located in london, WC1N 2PH with a Companies House number of 09547901. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in April 2015, it's largest shareholder is auric eusina ltd with a 71.4% stake. Biokemix Worldwide Ltd is a established, micro sized company, Pomanda has estimated its turnover at £351.3k with rapid growth in recent years.
Pomanda's financial health check has awarded Biokemix Worldwide Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
6 Weak
Size
annual sales of £351.3k, make it smaller than the average company (£25.7m)
- Biokemix Worldwide Ltd
£25.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 197%, show it is growing at a faster rate (6.7%)
- Biokemix Worldwide Ltd
6.7% - Industry AVG
Production
with a gross margin of 27.6%, this company has a comparable cost of product (27.6%)
- Biokemix Worldwide Ltd
27.6% - Industry AVG
Profitability
an operating margin of 28.7% make it more profitable than the average company (7%)
- Biokemix Worldwide Ltd
7% - Industry AVG
Employees
with 1 employees, this is below the industry average (59)
1 - Biokemix Worldwide Ltd
59 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Biokemix Worldwide Ltd
- - Industry AVG
Efficiency
resulting in sales per employee of £351.3k, this is less efficient (£559.1k)
- Biokemix Worldwide Ltd
£559.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Biokemix Worldwide Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 19 days, this is quicker than average (33 days)
- Biokemix Worldwide Ltd
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biokemix Worldwide Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (12 weeks)
0 weeks - Biokemix Worldwide Ltd
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 95.9%, this is a higher level of debt than the average (41.5%)
95.9% - Biokemix Worldwide Ltd
41.5% - Industry AVG
Biokemix Worldwide Ltd's latest turnover from December 2023 is estimated at £351.3 thousand and the company has net assets of £71.9 thousand. According to their latest financial statements, Biokemix Worldwide Ltd has 1 employee and maintains cash reserves of £1.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | 1 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||
Intangible Assets | |||||||||
Investments & Other | 1,337,398 | 1,324,445 | 262,170 | 69,709 | 69,709 | ||||
Debtors (Due After 1 year) | |||||||||
Total Fixed Assets | 1,337,398 | 1,324,445 | 262,170 | 69,709 | 69,709 | ||||
Stock & work in progress | |||||||||
Trade Debtors | 1 | 1 | |||||||
Group Debtors | 417,419 | 204,838 | 162,686 | 370,970 | 200,296 | ||||
Misc Debtors | 1,300 | 1,300 | 814 | 739 | |||||
Cash | 1,075 | 951 | 21,127 | 67,563 | 96,207 | 1 | 1 | ||
misc current assets | |||||||||
total current assets | 419,794 | 207,089 | 184,627 | 439,272 | 296,503 | 1 | 1 | 1 | 1 |
total assets | 1,757,192 | 1,531,534 | 446,797 | 508,981 | 366,212 | 1 | 1 | 1 | 1 |
Bank overdraft | |||||||||
Bank loan | |||||||||
Trade Creditors | 13,530 | 13,530 | 10,930 | 1,830 | |||||
Group/Directors Accounts | 501,986 | 354,286 | 235,782 | 228,950 | 86,692 | ||||
other short term finances | 15,714 | 21,157 | 92,531 | 122,973 | |||||
hp & lease commitments | |||||||||
other current liabilities | 62,367 | 30,342 | 38,274 | 13,527 | 6,968 | ||||
total current liabilities | 577,883 | 413,872 | 306,143 | 336,838 | 216,633 | ||||
loans | 1,107,393 | 1,025,736 | 44,460 | 45,000 | |||||
hp & lease commitments | |||||||||
Accruals and Deferred Income | |||||||||
other liabilities | |||||||||
provisions | |||||||||
total long term liabilities | 1,107,393 | 1,025,736 | 44,460 | 45,000 | |||||
total liabilities | 1,685,276 | 1,439,608 | 350,603 | 381,838 | 216,633 | ||||
net assets | 71,916 | 91,926 | 96,194 | 127,143 | 149,579 | 1 | 1 | 1 | 1 |
total shareholders funds | 71,916 | 91,926 | 96,194 | 127,143 | 149,579 | 1 | 1 | 1 | 1 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | |||||||||
Amortisation | |||||||||
Tax | |||||||||
Stock | |||||||||
Debtors | 212,581 | 42,638 | -208,209 | 371,708 | 200,295 | 1 | |||
Creditors | 2,600 | 9,100 | 1,830 | ||||||
Accruals and Deferred Income | 32,025 | -7,932 | 24,747 | 13,527 | 6,968 | ||||
Deferred Taxes & Provisions | |||||||||
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | 12,953 | 1,062,275 | 192,461 | 69,709 | 69,709 | ||||
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | |||||||||
Group/Directors Accounts | 147,700 | 118,504 | 6,832 | 228,950 | 86,692 | ||||
Other Short Term Loans | -15,714 | -5,443 | -71,374 | 92,531 | 122,973 | ||||
Long term loans | 81,657 | 981,276 | -540 | 45,000 | |||||
Hire Purchase and Lease Commitments | |||||||||
other long term liabilities | |||||||||
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | 124 | -20,176 | -46,436 | 67,563 | 96,207 | -1 | 1 | ||
overdraft | |||||||||
change in cash | 124 | -20,176 | -46,436 | 67,563 | 96,207 | -1 | 1 |
Perform a competitor analysis for biokemix worldwide ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in WC1N area or any other competitors across 12 key performance metrics.
BIOKEMIX WORLDWIDE LTD group structure
Biokemix Worldwide Ltd has no subsidiary companies.
Ultimate parent company
BIOKEMIX WORLDWIDE LTD
09547901
Biokemix Worldwide Ltd currently has 2 directors. The longest serving directors include Mr Sameer Bajaj (Jun 2019) and Mr Sameer Bajaj (Jun 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Sameer Bajaj | England | 54 years | Jun 2019 | - | Director |
Mr Sameer Bajaj | England | 54 years | Jun 2019 | - | Director |
P&L
December 2023turnover
351.3k
+274%
operating profit
100.8k
0%
gross margin
27.7%
-0.73%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
71.9k
-0.22%
total assets
1.8m
+0.15%
cash
1.1k
+0.13%
net assets
Total assets minus all liabilities
company number
09547901
Type
Private limited with Share Capital
industry
46750 - Wholesale of chemical products
20590 - Manufacture of other chemical products n.e.c.
21200 - Manufacture of pharmaceutical preparations
incorporation date
April 2015
age
10
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
biokemix europe ltd (December 2017)
accountant
-
auditor
-
address
1 doughty street, london, WC1N 2PH
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biokemix worldwide ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOKEMIX WORLDWIDE LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|